Lifecore Biomedical Files 8-K

Ticker: LFCR · Form: 8-K · Filed: Nov 21, 2024 · CIK: 1005286

Lifecore Biomedical, Inc. \De\ 8-K Filing Summary
FieldDetail
CompanyLifecore Biomedical, Inc. \De\ (LFCR)
Form Type8-K
Filed DateNov 21, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, company-information

Related Tickers: LNDC

TL;DR

Lifecore Biomedical (LNDC) filed an 8-K, confirming its address and former name (Landec Corp).

AI Summary

On November 21, 2024, Lifecore Biomedical, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 3515 Lyman Boulevard, Chaska, Minnesota, 55318. Lifecore Biomedical, Inc. was formerly known as Landec Corp. until a name change on December 22, 1995.

Why It Matters

This filing confirms the current operational details and corporate history of Lifecore Biomedical, Inc., providing essential information for investors and stakeholders.

Risk Assessment

Risk Level: low — This is a routine corporate filing with no new material financial or operational information that would inherently increase risk.

Key Players & Entities

  • Lifecore Biomedical, Inc. (company) — Registrant
  • November 21, 2024 (date) — Date of Report
  • 3515 Lyman Boulevard, Chaska, Minnesota, 55318 (address) — Principal executive offices
  • Landec Corp (company) — Former company name
  • December 22, 1995 (date) — Date of name change

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is Lifecore Biomedical, Inc.

In which state was Lifecore Biomedical, Inc. incorporated?

Lifecore Biomedical, Inc. was incorporated in Delaware.

What is the IRS Employer Identification Number for Lifecore Biomedical, Inc.?

The IRS Employer Identification Number is 94-3025618.

What was the former name of Lifecore Biomedical, Inc.?

The former name of Lifecore Biomedical, Inc. was Landec Corp.

When did the name change from Landec Corp to Lifecore Biomedical, Inc. occur?

The date of the name change was December 22, 1995.

Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-11-21 07:55:36

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On November 21, 2024, Lifecore Biomedical, Inc. (the "Company") made available certain investor presentation materials (the "Investor Presentation"). A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 7.01. The information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Lifecore Biomedical, Inc. Investor Presentation dated November 21, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 21, 2024 LIFECORE BIOMEDICAL, INC. By: /s/ Ryan D. Lake Ryan D. Lake Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.